← SynDRA
LICOSTINEL
SynDRA canonical compound SYN0002157 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | GRIN1 | GRIN2A | GRIN3A |
|---|
| Mechanism of action | NMDA receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- NMDA receptor antagonist
- F2 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- GRIN2B
- GRIN2C
- GRIN2D
- GRIN3B
Drug classes
- Excitatory Amino Acid Antagonists
Cross-references
Synonyms
- ACEA-1021
- ACEA1021
- UNII-3Z3037LJTC
- 6,7-Dichloro-5-nitro-2,3-quinoxalinedione
- 5-Nitro-6,7-dichloro-2,3-quinoxalinedione
- 5-Nitro-6,7-dichloro-1,4-dihydro-2,3-quinoxalinedione
- 6,7-Dichloro-1,4-dihydro-5-nitro-2,3-quinoxalinedione
- CHEMBL289832
- 3Z3037LJTC
- 6,7-dichloro-5-nitro-1,4-dihydroquinoxaline-2,3-dione
- 6,7-DICHLORO-5-NITROQUINOXALINE-2,3(1H,4H)-DIONE
- 2,3-Quinoxalinedione, 6,7-dichloro-1,4-dihydro-5-nitro-
- Licostinel [USAN]
- Licostinel [USAN:INN]
- C8H3Cl2N3O4
- AC1NUOFE
- Licostinel (USAN/
- ACEA 1021
- licostinelum
- RefChem:924741
- DTXCID3087837
- MFCD00672687
- LICOSTINEL [MI]
- LICOSTINEL [INN]
- Licostinel (USAN/INN)
- MLS006010858
- SCHEMBL464947
- orb1305026
- SCHEMBL5274587
- SCHEMBL30546249
- CHFSOFHQIZKQCR-UHFFFAOYSA-N
- BDBM50038161
- EX-A14331
- AKOS030627460
- AKOS040748747
- AS-55059
- DA-54920
- SMR002530535
- SY245109
Look up LICOSTINEL in the interactive SynDRA portal →